ArticleHaemophilia : the official journal of the World Federation of Hemophilia2020

SHP656, a polysialylated recombinant factor VIII (PSA-rFVIII): First-in-human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A.

Andreas Tiede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.